A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks.
In rural Oklahoma, a brand new medical school sits in the Cherokee Nation, training Nation members to become physicians at Nation clinics. Oklahoma State University College of Osteopathic Medicine at the Cherokee Nation is the first tribally associated medical school in the country.
Sarah Fuller is the starting goalkeeper for the Vanderbilt women’s soccer team, but last Sunday she took on a different athletic role for the school as she became the first woman to play in a Power 5 Conference college football game.
The recent development, promises to be a huge boost to the annual fight against the seasonal flu, as plants can be engineered to produce viral proteins and cultivated at scale.
The US Food and Drug Administration (FDA) set a minimum effectiveness bar for COVID-19 vaccines at 50% for drugs seeking approval. This is the first COVID-19 candidate vaccine to produce data exceeding that mark.
After the team from MIT trained its model on tens of thousands of cough and dialog samples, the technology recognized 98.5 percent of coughs from people with confirmed COVID-19 cases. It identified 100 percent of people who were ostensibly asymptomatic, too.
Modern sensors have given conservationists a powerful new tool in the fight against poaching. A new research project at the University of Twente could harness this technology in yet another useful way, by mixing motion sensors with machine learning to recognize when wildlife is responding to a nearby threat.
Researchers at the University of Hong Kong performed a meta-analysis of 201 independent studies, comprising 198,213 total participants, that looked at the connection between prosocial behavior and well-being.
In the placebo-controlled study, published in European Neuropsychopharmacology, scientists from University of Basel and Maastricht University gave volunteers either a small dose of LSD or a placebo, then measured their ability to pay attention and process information, as well as keeping an eye on their mood.
The team from Australia’s Flinders University has developed a breath test that can detect exhaled breath profiles associated with head and neck cancers, with the tool demonstrating a high degree of accuracy in early trials.
